134 related articles for article (PubMed ID: 17080293)
21. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer.
Ling ZQ; Li P; Ge MH; Hu FJ; Fang XH; Dong ZM; Mao WM
Dig Dis Sci; 2011 Oct; 56(10):2992-3004. PubMed ID: 21674174
[TBL] [Abstract][Full Text] [Related]
22. Context-dependent bidirectional regulation of the MutS homolog 2 by transforming growth factor β contributes to chemoresistance in breast cancer cells.
Yu Y; Wang Y; Ren X; Tsuyada A; Li A; Liu LJ; Wang SE
Mol Cancer Res; 2010 Dec; 8(12):1633-42. PubMed ID: 21047769
[TBL] [Abstract][Full Text] [Related]
23. Functional mechanisms for human tumor suppressors.
Sun W; Yang J
J Cancer; 2010 Sep; 1():136-40. PubMed ID: 20922055
[TBL] [Abstract][Full Text] [Related]
24. Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2.
Martin SA; McCarthy A; Barber LJ; Burgess DJ; Parry S; Lord CJ; Ashworth A
EMBO Mol Med; 2009 Sep; 1(6-7):323-37. PubMed ID: 20049736
[TBL] [Abstract][Full Text] [Related]
25. Role of MutS homolog 2 (MSH2) in intestinal myofibroblast proliferation during Crohn's disease stricture formation.
Floer M; Binion DG; Nelson VM; Manley S; Wellner M; Sadeghi S; Behmaram B; Sewell C; Otterson MF; Kucharzik T; Rafiee P
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G581-90. PubMed ID: 18635600
[TBL] [Abstract][Full Text] [Related]
26. Mismatch repair pathway: molecules, functions, and role in colorectal carcinogenesis.
Sameer AS; Nissar S; Fatima K
Eur J Cancer Prev; 2014 Jul; 23(4):246-57. PubMed ID: 24614649
[TBL] [Abstract][Full Text] [Related]
27. Microsatellite instability: an update.
Yamamoto H; Imai K
Arch Toxicol; 2015 Jun; 89(6):899-921. PubMed ID: 25701956
[TBL] [Abstract][Full Text] [Related]
28. The role of the human DNA mismatch repair gene hMSH2 in DNA repair, cell cycle control and apoptosis: implications for pathogenesis, progression and therapy of cancer.
Seifert M; Reichrath J
J Mol Histol; 2006 Sep; 37(5-7):301-7. PubMed ID: 17080293
[TBL] [Abstract][Full Text] [Related]
29. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
[TBL] [Abstract][Full Text] [Related]
30. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic mismatch repair hMSH2 and hMLH1 gene expression profiles in primary non-small cell lung carcinomas.
Vageli D; Daniil Z; Dahabreh J; Karagianni E; Vamvakopoulou DN; Ioannou MG; Scarpinato K; Vamvakopoulos NC; Gourgoulianis KI; Koukoulis GK
Lung Cancer; 2009 Jun; 64(3):282-8. PubMed ID: 19056144
[TBL] [Abstract][Full Text] [Related]
32. Functional analysis of HNPCC-related missense mutations in MSH2.
Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
[TBL] [Abstract][Full Text] [Related]
33. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.
Skeldon SC; Semotiuk K; Aronson M; Holter S; Gallinger S; Pollett A; Kuk C; van Rhijn B; Bostrom P; Cohen Z; Fleshner NE; Jewett MA; Hanna S; Shariat SF; Van Der Kwast TH; Evans A; Catto J; Bapat B; Zlotta AR
Eur Urol; 2013 Feb; 63(2):379-85. PubMed ID: 22883484
[TBL] [Abstract][Full Text] [Related]
34. Alterations of p53, BCL-2, and hMSH2 protein expression in the normal brain tissues, gliosis, and gliomas.
Hussein MR; El-Ghorori RM; El-Rahman YG
Int J Exp Pathol; 2006 Aug; 87(4):297-306. PubMed ID: 16875495
[TBL] [Abstract][Full Text] [Related]
35. Signalling cell cycle arrest and cell death through the MMR System.
O'Brien V; Brown R
Carcinogenesis; 2006 Apr; 27(4):682-92. PubMed ID: 16332722
[TBL] [Abstract][Full Text] [Related]
36. Tissue microarray analysis of hMSH2 expression predicts outcome in men with prostate cancer.
Prtilo A; Leach FS; Markwalder R; Kappeler A; Burkhard FC; Cecchini MG; Studer UE; Thalmann GN
J Urol; 2005 Nov; 174(5):1814-8; discussion 1818. PubMed ID: 16217293
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]